This PowerPoint presentation from the Blood XMRV Scientific Research Working Group has been posted on the Blood Products Advisory Committee meeting website since I last checked the site. You have to scroll clear to the bottom and click on the report by Graham Simmons. http://www.fda.gov/AdvisoryCommitte.../BloodProductsAdvisoryCommittee/ucm221857.htm You need to have PowerPoint to read it; I had to download an adapter to read it with my older version. I think it's good news. This is the kind of systematic research we need to have being done. I was somewhat worried that the "spiked" samples they were testing (so that they'd all be testing the same thing) wouldn't necessarily behave the way the "wild" virus does in real patients, but it looks like they're considering that, too. In phases III and IV they will use samples from real live people.